Pharmaceutical companies operate in one of the most heavily regulated industries in the world. From early product development to post-market surveillance, each step demands strict compliance with a complex web of global regulations. A Regulatory Management System (RMS) helps make that compliance manageable. Far more than a digital filing cabinet, an RMS is a centralized,
Author Archives: Jawad Kamal
SANTA CLARA, Calif., April 1, 2025—ValGenesis, Inc. ValGenesis Inc., a leading provider of enterprise validation lifecycle management solutions, announced that Scigeniq has successfully implemented ValGenesis VLMS 5.0, modernizing its qualification and validation processes. As a life sciences technology and consulting firm specializing in compliance solutions, Scigeniq adopted VLMS to streamline internal processes and strengthen its
System integration has been one of the most time-consuming, expensive, and risky aspects of implementing software solutions in pharmaceutical companies for years. Whether connecting a Quality Management System (QMS) to an Enterprise Resource Planning (ERP) platform or linking different parts of a Manufacturing system, the process has traditionally relied on complex, custom-built back-end integrations. These
For growing life sciences companies, investing in technology is a critical key to unlocking rapid growth. But the question of where to start can be perplexing. One great choice is to address the need to plan and manage employee training activities. Selecting the right Training Management System (TMS) can immediately address regulatory requirements while improving
The pharmaceutical market in the Middle East and North Africa (MENA) region is well positioned for significant growth over the next ten years. As the region matures, its regulatory frameworks will continue to strengthen, the market will expand, and local companies will increasingly compete on the global stage. This blog explores these trends, the factors
The pharmaceutical industry is undergoing a significant shift, driven by the need for increased efficiency, stricter regulatory compliance, and the rise of Industry 4.0. Abdullah Othman, Chief Product and Quality Officer at Scigeniq, and Aghiles Mitiche, Sr.Manager of Operational Excellence at Julphar, recently attended Forum A3P Middle East and conducted a workshop highlighting electronic Quality
The pharmaceutical landscape in the Middle East and North Africa (MENA) region is undergoing a rapid transformation, and Saudi Arabia is firmly at its helm. With its proactive regulatory framework, ambitious Vision 2030 objectives, and substantial investment in local production, the Kingdom is shaping the future of the region’s pharma industry. Smart pharmaceutical companies and
For fast-growing pharma companies, managing assets effectively is crucial for maintaining compliance, ensuring quality, and optimizing operations. An Asset Management System (AMS) can play a central role in this effort, offering a structured approach to tracking and maintaining the physical and digital assets vital to research, development, and production. Why Invest in an Asset Management
As a software vendor providing quality and regulatory solutions to the pharmaceutical industry, Scigeniq is keenly aware of artificial intelligence’s (AI) transformative potential. The impact goes far beyond ChatGPT and its cousins’ generative capabilities; the impact on quality systems is much more focused on data-driven capabilities. We want to share how AI is shaping our
The Scigeniq team was present in force at the FCE Pharma conference earlier in June. The conference was huge and underscored the exciting trends and developments in the Latin American Pharma market. Focused on the Pharma Industry FCE Brazil is a major trade show and conference focused on the pharmaceutical industry. Held annually, the event